Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Spark Therap (ONCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,304,920
  • Shares Outstanding, K 37,570
  • Annual Sales, $ 12,070 K
  • Annual Income, $ -253,480 K
  • 36-Month Beta 2.39
  • Price/Sales 182.16
  • Price/Cash Flow N/A
  • Price/Book 3.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.94
  • Number of Estimates 10
  • High Estimate -0.15
  • Low Estimate -2.44
  • Prior Year -1.90
  • Growth Rate Est. (year over year) +50.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.59 +18.92%
on 08/07/18
87.88 -30.19%
on 07/17/18
-23.62 (-27.80%)
since 07/13/18
3-Month
51.59 +18.92%
on 08/07/18
96.59 -36.48%
on 07/09/18
-17.18 (-21.88%)
since 05/14/18
52-Week
41.06 +49.42%
on 12/11/17
96.59 -36.48%
on 07/09/18
-18.26 (-22.94%)
since 08/14/17

Most Recent Stories

More News
Shares of Spark Therapeuti Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (ONCE , RTRX , PTCT , ENTA , ESPR )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

PTCT : 44.89 (+4.06%)
ONCE : 61.35 (+4.87%)
RTRX : 26.86 (+4.35%)
Turkey Ruins Week for Dow, S&P

Turkey Ruins Week for Dow, S&P

HUBG : 52.15 (+1.16%)
A : 66.75 (+1.23%)
R : 77.45 (+1.26%)
WAL : 57.12 (+1.33%)
ONCE : 61.35 (+4.87%)
AVLR : 36.03 (-6.44%)
BLUE : 156.40 (+0.26%)
PGR : 62.29 (+0.53%)
DWDP : 67.56 (+1.46%)
Spark Therapeuti Shares Down 32.0% Since SmarTrend's Sell Call (ONCE)

SmarTrend identified a Downtrend for Spark Therapeuti (NASDAQ:ONCE) on July 16th, 2018 at $83.68. In approximately 3 weeks, Spark Therapeuti has returned 32.03% as of today's recent price of $56.88.

ONCE : 61.35 (+4.87%)
Biotech Stock Roundup: Regeneron Shines, BLUE Surges, ONCE Plunges

The last leg of Q2 earnings in the biotech sector saw Regeneron firing all cylinders. The company also collaborated with bluebird bio, which impressed investors.

ONCE : 61.35 (+4.87%)
BLUE : 156.40 (+0.26%)
VRTX : 175.93 (+0.50%)
GILD : 77.31 (+0.18%)
REGN : 366.23 (-0.06%)
Spark Therapeutics (ONCE) Q2 Earnings Beat Estimates

Spark Therapeutics (ONCE) delivered earnings and revenue surprises of 581.40% and -14.44%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

ONCE : 61.35 (+4.87%)
Today's Research Reports on Trending Tickers: Spark Therapeutics and bluebird bio

NEW YORK, NY / ACCESSWIRE / August 7, 2018 / U.S. markets closed in the green on Monday, as Nasdaq surged for the fifth consecutive session, on a batch of strong corporate earnings, amidst ongoing trade-related...

ONCE : 61.35 (+4.87%)
Spark Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Progress

As of July 13, 2018, preliminary Phase 1/2 data for investigational SPK-8011 for hemophilia A show:

ONCE : 61.35 (+4.87%)
Spark Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Spark Therapeutics, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 8:30:00 AM Eastern Time....

ONCE : 61.35 (+4.87%)
Spark Therapeutics Recognized for Second-straight Year as One of Philadelphia's "Best Places to Work" by the Philadelphia Business Journal

Spark Therapeutics (NASDAQ: ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has been named one of Philadelphia's "Best...

ONCE : 61.35 (+4.87%)
Spark Therapeutics to Host Conference Call on Tuesday, Aug. 7 at 8:30 a.m. ET to Discuss Second Quarter Results and Recent Business Highlights

PHILADELPHIA, July 31, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference...

ONCE : 61.35 (+4.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More Share

Trade ONCE with:

Business Summary

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in...

See More

Key Turning Points

2nd Resistance Point 63.26
1st Resistance Point 62.30
Last Price 61.35
1st Support Level 59.51
2nd Support Level 57.68

See More

52-Week High 96.59
Fibonacci 61.8% 75.38
Fibonacci 50% 68.82
Fibonacci 38.2% 62.27
Last Price 61.35
52-Week Low 41.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar